SCHEMBL20161835

SCHEMBL20161835

CC(C)NC1CCN(C(C)C)CC1C

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.30
DRD4 P21917 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20711787 1.00 KDM1A (0.30) KDM1ADRD4
SCHEMBL27089681 1.00 KDM1A (0.30) KDM1ADRD4
SCHEMBL20711932 1.00 KDM1A (0.30) KDM1ADRD4
SCHEMBL20161756 1.00 KDM1A (0.30) KDM1ADRD4
SCHEMBL24467188 0.91 KAT2B (0.33)
SCHEMBL27089688 0.91 KAT2B (0.33)
SCHEMBL20161755 0.91 KAT2B (0.33)
SCHEMBL23365998 0.86 KDM1A (0.34) KDM1A
SCHEMBL23365921 0.86 KDM1A (0.34) KDM1A
SCHEMBL24467179 0.85 KDM1A (0.35) KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3534899-B1 COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE CORVUS PHARMACEUTICALS INC (US) 2022-06-01 EP disclosed
WO-2018089261-A2 COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE CORVUS PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed